Insiders · Profile

Panzara Michael A.

See Remarks at Wave Life Sciences. Filing since 12 Jul 2017. CIK 0001679039

Company
Date
Role
Action
Shares
Amount
Of holding
5 May 2022
See Remarks
Sold, plan not stated
16,714
$28.75K
13.3%
16 Feb 2022
See Remarks
Sold, plan not stated
10,603
$24.49K
12.3%
16 Feb 2021
See Remarks
Sold, plan not stated
2,929
$30.96K
3.3%
18 Feb 2020
Chief Medical Officer
Sold, plan not stated
2,981
$23.40K
7.0%
5 Jul 2019
Chief Medical Officer
Sold, plan not stated
3,058
$82.37K
6.7%
11 Mar 2019
Franchise Lead, Neurology
Sold, plan not stated
7,000
$336.00K
13.4%
19 Feb 2019
Franchise Lead, Neurology
Sold, plan not stated
1,837
$67.67K
4.7%
16 Feb 2018
Franchise Lead, Neurology
Sold, plan not stated
511
$26.62K
1.3%
15 Feb 2018
Franchise Lead, Neurology
Sold, plan not stated
18,750
$937.50K
32.1%
12 Jul 2017
Franchise Lead, Neurology
Sold, plan not stated
7,414
$123.62K
32.6%
10 decisions on file.